Study for cardiomyopathy linked to family or genes
Treatments studied
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at people with cardiomyopathy (or related heart muscle conditions) and those who may be at risk because of family history or genetic test results. It may help researchers better understand who is likely to develop the condition and how best to monitor or support them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult able to consent, or a child with a parent/guardian who can consent
- You need a confirmed diagnosis of cardiomyopathy or a related condition, or have a close family member with it
- You may qualify if you have a genetic variant that could increase risk for cardiomyopathy
- Your family member must have a cardiomyopathy-related condition (not just unrelated heart problems)
- You must be able to provide consent or have a parent/guardian who can
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational study looks at people with cardiomyopathy or myocarditis, and people with a close family history of these conditions. It aims to better understand the condition and what factors may be involved.
This study looks at genetic (DNA) changes that may cause cardiomyopathy, a disease where the heart muscle is weakened. It may help families understand possible causes and inform future care.
This study looks at the genes behind cardiomyopathy (a disease of the heart muscle). It may help explain why it happens in your family and guide better care for you and relatives.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
This program builds a registry of people diagnosed with hypertrophic cardiomyopathy and their family members. By collecting health information over time, researchers hope to better understand the condition and improve care.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.